ArticleFrontiers in pharmacology2024

Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS).

KaiLi Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.